Triamterene and Hydrochlorothiazide
- Product NDC
- 42291-842
- 11-digit product format
- 422910842
- Labeler code
- 42291
- Product ID
- 42291-842_d5ca211e-def5-d9aa-e053-2995a90a3570
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA071251
- Marketing category
- ANDA
- Marketing start
- 2014-10-14
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-842-50 | 42291084250 | 500 TABLET in 1 BOTTLE (42291-842-50) | 500 tablet | 2014-10-14 | 0000-00-00 | No | No | Current |